NEW YORK, NY / ACCESSWIRE / November 1, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.
RDI Initiates Coverage on:
GeneNews’ stock had no change Wednesday, to close the day at $0.045. The stock recorded a trading volume of 127,000 shares, which was above its three months average volume of 114,384 shares. In the last year, GeneNews' shares have traded in a range of 0.05 - 0.24. The share price has fallen 0% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.058 is lower than its 200-day moving average of $0.074. Shares of GeneNews have fallen approximately 78.26 percent year-to-date.
Access RDI's GeneNews Limited Research Report at:
On Wednesday, shares of
Access RDI's Medicure Inc. Research Report at:
Access RDI's Aphria Inc. Research Report at:
On Wednesday, shares of Resverlogix recorded a trading volume of 74,770 shares, which was below the three months average volume of 108,696 shares. The stock ended the day 1.83% higher at $3.33. The share price has fallen 22.74% from its 52
Access RDI's Resverlogix Corp. Research Report at:
Our Actionable Research on GeneNews Limited (TSX
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.